Variable Porosity Silicone Wound Dressing for Exudate Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing wound dressings often cause wound desiccation and infection due to fixed porosity, which hinders optimal healing and requires frequent changes, especially in chronic wounds.
Innovation Solution
A dressing with variable porosity controlled by clinicians, composed of a silicone membrane with slit openings and biological layers that include Aloe, gelatin, and ECM, allowing fluid exudate to pass into a secondary dressing without disrupting healing, and incorporating anti-scar compounds like salinomycin for enhanced healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If a dressing with fixed porosity is used, then the structure is simple and easy to manufacture, but it causes wound desiccation and infection due to inability to adapt to varying exudate levels
Solution Approach 1:
The patent applies the dynamics principle by making the dressing porosity variable rather than fixed. The dressing transitions from a static structure to a dynamic one where pore size and openness can change in response to wound conditions, exudate levels, and clinician requirements, allowing adaptation without changing the fundamental dressing architecture
Solution Approach 2:
The patent implements parameter changes by allowing the porosity parameter of the dressing to be adjusted according to wound needs. The dressing can modify its physical properties (pore size, permeability) based on wound exudate levels and healing stage, enabling a single dressing design to serve multiple wound types and stages
2Reliability
If frequent dressing changes are performed to prevent desiccation and infection, then wound healing quality improves, but treatment time and cost increase
Solution Approach 1:
The patent applies continuity of useful action by designing a dressing that maintains its protective and therapeutic functions continuously over an extended period. The variable porosity ensures continuous appropriate moisture management without requiring removal and replacement, maintaining healing quality while reducing the frequency of disruptive dressing changes
Solution Approach 2:
The patent implements preliminary action by incorporating anti-scar compounds into the dressing structure in advance. This pre-inclusion of therapeutic agents prevents scarring proactively during the healing process, eliminating the need for additional separate treatments and reducing overall treatment time
3Adaptability or versatility
If multiple specialized dressings are inventoried for different wound types, then wound-specific treatment optimization improves, but inventory complexity and cost increase
Solution Approach 1:
The patent applies universality by designing a single dressing that can effectively treat multiple wound types (acute and chronic wounds) through its variable porosity feature. The dressing can be adjusted to suit different wound requirements, making it a multi-functional solution that replaces the need for multiple specialized dressings in hospital inventory
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dressing maintains a moist environment, reduces wound desiccation and scarring, minimizes pain, and is cost-effective by allowing a single primary dressing for both acute and chronic wounds, with improved healing kinetics and reduced maintenance costs.
Implementation Method 1
In vitro, the Aloe component has been demonstrated to cause a variety of cells to attach and proliferate; as well as increase synthesis of collagen and alpha smooth muscle actin
Implementation Method 2
The first coat will contact the wound after the second coat of hypoallergenic bovine spongiform encephalopathy (BSE)-free United States Pharmaceutical (USP)-grade gelatin interacts with fibrin in the wound to achieve early adherence
Implementation Method 3
The present invention enables the clinician to move the fluid exuding from the wound through the primary dressing into an absorbent secondary dressing
Implementation Method 4
The present invention provides a dressing that possesses all the properties and attributes of an ideal skin substitute and, in addition, has 'variable porosity' controlled by the clinician from essentially zero porosity to what the wound requires
Data Source
AI summary
An improved skin substitute is presented comprised of a silicone layer backed up with a woven nylon fabric layer, the silicone layer possessing a regular pattern of slits that permit the porosity of the skin substitute to be adjusted by clinicians by means of applying tension to the skin substitute that differentially opens the slits. A variety of therapeutic substances can be applied to the skin substitute to promote healing, including aloe and other medicinal preparations. A layer of water soluble or water insoluble anti-scar compound is also present, the preferred compound being salinomycin.